These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4301182)

  • 1. [The illusion of attenuated foot-and-mouth disease virus by interference between avirulent and virulent virus of the same strain].
    Bauer K
    Zentralbl Veterinarmed B; 1968; 15(7):758-71. PubMed ID: 4301182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interference and sensitivity of virulent and attenuated foot-and-mouth disease virus to interferon].
    Oleĭnikov OG
    Veterinariia; 1971 Jan; 1():39-41. PubMed ID: 4325014
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of pretreatment by immunity adjuvants on the multiplication of foot-and-mouse disease virus in adult mouse].
    Gorhe D; Asso J; Paraf A
    Ann Inst Pasteur (Paris); 1968 Sep; 115(3):446-64. PubMed ID: 4304117
    [No Abstract]   [Full Text] [Related]  

  • 4. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference between modified and virulent strains of foot-and-mount disease virus.
    Sellers RF; Mowat GN
    Arch Gesamte Virusforsch; 1968; 23(1):20-6. PubMed ID: 4300585
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiplication of an attenuated RV11 strain (type SAT12) of foot-and-mouth disease virus in sheep.
    Howell PG
    Onderstepoort J Vet Res; 1966 Jun; 33(1):15-24. PubMed ID: 4290897
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential of recombination for the production of foot-and-mouth disease virus vaccine strains.
    McCahon D; King AM; Slade WR; Skinner HH; Haresnape J
    Dev Biol Stand; 1980; 46():223-30. PubMed ID: 6244999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nucleotide sequence of the RNA polymerase gene attenuated by a variant of foot-and-mouth disease virus and its comparison with the virulence of related variants of subtype A22].
    Lomakina NF; Rybakov SS
    Mol Gen Mikrobiol Virusol; 1996; (1):35-40. PubMed ID: 8786750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of temperature during passage on the properties of attenuated foot and mouth disease virus].
    Urvantsev NM; Siusiukin AA; Sergeev VA; Prokhorov VV
    Veterinariia; 1971 Jan; 1():37-9. PubMed ID: 4325013
    [No Abstract]   [Full Text] [Related]  

  • 10. Interference in modified foot-and-mouth disease viruses.
    Seibold HR
    Bull Off Int Epizoot; 1966; 65(11):2017-22. PubMed ID: 4296534
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental increase of nonspecific resistance to infection of the mouse with foot-and-mouth disease virus].
    Lübke A
    Zentralbl Bakteriol Orig; 1964 Nov; 194(3):306-18. PubMed ID: 4284151
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
    Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
    Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Foot and mouth disease induced by a vaccinal strain of the virus].
    Bychkovskii VN
    Vrach Delo; 1972 Aug; 8():150-1. PubMed ID: 4342149
    [No Abstract]   [Full Text] [Related]  

  • 14. Genomic characterization of virulent, attenuated, and revertant passages of a North American porcine reproductive and respiratory syndrome virus strain.
    Grebennikova TV; Clouser DF; Vorwald AC; Musienko MI; Mengeling WL; Lager KM; Wesley RD; Biketov SF; Zaberezhny AD; Aliper TI; Nepoklonov EA
    Virology; 2004 Apr; 321(2):383-90. PubMed ID: 15051397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus.
    Janssen R; Gonzalez-Scarano F; Nathanson N
    Lab Invest; 1984 Apr; 50(4):447-55. PubMed ID: 6708454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foot and mouth disease virus production on microcarrier-grown cells.
    Meignier B; Mougeot H; Favre H
    Dev Biol Stand; 1980; 46():249-56. PubMed ID: 6245001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical characterization of a foot-and-mouth disease virus strain attenuated for cattle. Brief report.
    Polacino P; Kaplan G; Yafal AG; Palma EL
    Arch Virol; 1986; 88(1-2):143-50. PubMed ID: 3006639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Foot-and-mouth virus component responsible for immunogenesis].
    Salazhov EL; Ivanov VS
    Veterinariia; 1970 Sep; 9():38-40. PubMed ID: 4323895
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on viral interference induced by rinderpest virus: 3. Interferon induction by attenuated and virulent strains of rinderpest virus in tissue culture.
    Hussain SF; Akhtar AS; Rweyemamu MM; Kaminjolo JS; Mugera GM
    Bull Anim Health Prod Afr; 1982 Mar; 30(1):1-6. PubMed ID: 7186805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.